Concurrent diagnoses of treatment-induced neuropathy of diabetes and restless leg syndrome

Background: To describe the clinical manifestations, treatment, and prognosis of a patient with type 1 diabetes (T1D) and concurrent diagnoses of painful treatment-induced neuropathy of diabetes (TIND) and restless leg syndrome (RLS). Case report: A 36-year-old man with newly diagnosed T1D experienc...

Full description

Bibliographic Details
Main Authors: Sarah Kanbour, Aanika Balaji, Nicholas Maragakis, Nicholas Stanley Clarke, Nestoras Mathioudakis
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Journal of Clinical and Translational Endocrinology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214624523000059
_version_ 1797798879875301376
author Sarah Kanbour
Aanika Balaji
Nicholas Maragakis
Nicholas Stanley Clarke
Nestoras Mathioudakis
author_facet Sarah Kanbour
Aanika Balaji
Nicholas Maragakis
Nicholas Stanley Clarke
Nestoras Mathioudakis
author_sort Sarah Kanbour
collection DOAJ
description Background: To describe the clinical manifestations, treatment, and prognosis of a patient with type 1 diabetes (T1D) and concurrent diagnoses of painful treatment-induced neuropathy of diabetes (TIND) and restless leg syndrome (RLS). Case report: A 36-year-old man with newly diagnosed T1D experienced the onset of painful lower extremity neuropathy symptoms after a hemoglobin A1C drop from 15% to 6.6% over 1 month upon initiation of insulin pump therapy. His pain was refractory to conventional diabetic neuropathy management, and TIND was diagnosed given the rapid A1C reduction. He was later found to have anemia and diagnosed with concurrent RLS, for which he was treated with carbidopa-levodopa and later pramipexole. Over the course of 18 months, his neuropathic symptoms resolved completely. Discussion: TIND and RLS are both small fiber neuropathies with some shared clinical symptoms, including worsening symptoms at night. Sleep disturbance and the urge to move legs are more characteristic of RLS. Rapid A1C lowering, which may occur in patients with newly diagnosed T1D, may provoke TIND, while underlying iron-deficiency anemia is a risk factor for RLS. TIND may be poorly responsive to conventional diabetic neuropathy treatment and may take months to improve or resolve, while RLS is responsive to treatment with dopamine agonists. Conclusion: TIND should be suspected in T1D patients who have rapid A1C lowering (more than 2% drop in 3 months). In patients with refractory symptoms who have underlying iron deficiency anemia, sleep disturbance, and the urge to move their legs, RLS should be considered in the differential.
first_indexed 2024-03-13T04:10:59Z
format Article
id doaj.art-7a2d009845bb4d7c95836951b2cce255
institution Directory Open Access Journal
issn 2214-6245
language English
last_indexed 2024-03-13T04:10:59Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Journal of Clinical and Translational Endocrinology Case Reports
spelling doaj.art-7a2d009845bb4d7c95836951b2cce2552023-06-21T06:54:57ZengElsevierJournal of Clinical and Translational Endocrinology Case Reports2214-62452023-06-0128100143Concurrent diagnoses of treatment-induced neuropathy of diabetes and restless leg syndromeSarah Kanbour0Aanika Balaji1Nicholas Maragakis2Nicholas Stanley Clarke3Nestoras Mathioudakis4Johns Hopkins Hospital, Department of Internal Medicine, USA; Johns Hopkins Hospital, Division of Endocrinology, Diabetes and Metabolism, USAJohns Hopkins Hospital, Department of Internal Medicine, USAJohns Hopkins Hospital, Department of Neurology, USAJohns Hopkins Hospital, Department of Cardiothoracic Surgery, USAJohns Hopkins Hospital, Department of Internal Medicine, USA; Johns Hopkins Hospital, Division of Endocrinology, Diabetes and Metabolism, USA; Corresponding author. 601 N. Caroline St, Baltimore, MD 21287, USA.Background: To describe the clinical manifestations, treatment, and prognosis of a patient with type 1 diabetes (T1D) and concurrent diagnoses of painful treatment-induced neuropathy of diabetes (TIND) and restless leg syndrome (RLS). Case report: A 36-year-old man with newly diagnosed T1D experienced the onset of painful lower extremity neuropathy symptoms after a hemoglobin A1C drop from 15% to 6.6% over 1 month upon initiation of insulin pump therapy. His pain was refractory to conventional diabetic neuropathy management, and TIND was diagnosed given the rapid A1C reduction. He was later found to have anemia and diagnosed with concurrent RLS, for which he was treated with carbidopa-levodopa and later pramipexole. Over the course of 18 months, his neuropathic symptoms resolved completely. Discussion: TIND and RLS are both small fiber neuropathies with some shared clinical symptoms, including worsening symptoms at night. Sleep disturbance and the urge to move legs are more characteristic of RLS. Rapid A1C lowering, which may occur in patients with newly diagnosed T1D, may provoke TIND, while underlying iron-deficiency anemia is a risk factor for RLS. TIND may be poorly responsive to conventional diabetic neuropathy treatment and may take months to improve or resolve, while RLS is responsive to treatment with dopamine agonists. Conclusion: TIND should be suspected in T1D patients who have rapid A1C lowering (more than 2% drop in 3 months). In patients with refractory symptoms who have underlying iron deficiency anemia, sleep disturbance, and the urge to move their legs, RLS should be considered in the differential.http://www.sciencedirect.com/science/article/pii/S2214624523000059Treatment-induced neuropathy of diabetesRestless leg syndromeType 1 diabetesGlycemic control
spellingShingle Sarah Kanbour
Aanika Balaji
Nicholas Maragakis
Nicholas Stanley Clarke
Nestoras Mathioudakis
Concurrent diagnoses of treatment-induced neuropathy of diabetes and restless leg syndrome
Journal of Clinical and Translational Endocrinology Case Reports
Treatment-induced neuropathy of diabetes
Restless leg syndrome
Type 1 diabetes
Glycemic control
title Concurrent diagnoses of treatment-induced neuropathy of diabetes and restless leg syndrome
title_full Concurrent diagnoses of treatment-induced neuropathy of diabetes and restless leg syndrome
title_fullStr Concurrent diagnoses of treatment-induced neuropathy of diabetes and restless leg syndrome
title_full_unstemmed Concurrent diagnoses of treatment-induced neuropathy of diabetes and restless leg syndrome
title_short Concurrent diagnoses of treatment-induced neuropathy of diabetes and restless leg syndrome
title_sort concurrent diagnoses of treatment induced neuropathy of diabetes and restless leg syndrome
topic Treatment-induced neuropathy of diabetes
Restless leg syndrome
Type 1 diabetes
Glycemic control
url http://www.sciencedirect.com/science/article/pii/S2214624523000059
work_keys_str_mv AT sarahkanbour concurrentdiagnosesoftreatmentinducedneuropathyofdiabetesandrestlesslegsyndrome
AT aanikabalaji concurrentdiagnosesoftreatmentinducedneuropathyofdiabetesandrestlesslegsyndrome
AT nicholasmaragakis concurrentdiagnosesoftreatmentinducedneuropathyofdiabetesandrestlesslegsyndrome
AT nicholasstanleyclarke concurrentdiagnosesoftreatmentinducedneuropathyofdiabetesandrestlesslegsyndrome
AT nestorasmathioudakis concurrentdiagnosesoftreatmentinducedneuropathyofdiabetesandrestlesslegsyndrome